An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
A small app called Peptide Tracker has started a "Founding Member" program that asks users to support the app financially without putting any features behind a paywall. In plain terms: the app is offering people a way to chip in money to help keep it running and growing, while still letting everyone use its core features for free. Peptide Tracker is an app aimed at people who follow peptide news and information — think of it like a specialized news and tracking tool for updates about peptide drugs (the class that includes things like semaglutide). It’s not a peptide itself; it’s software that collects and displays headlines, study alerts, and maybe personal tracking tools for users who want to follow developments in the field. The founding membership is a way for early supporters to contribute and get recognition or small perks, rather than paying to unlock basic functionality. The announcement says the program is meant to fund the app while keeping it accessible. This isn’t a clinical trial or new drug finding — it’s a business move. The coverage I saw didn’t report user numbers, financial targets, or detailed perks, so we don’t know how many people have joined or how much money the program aims to raise. The key claim is procedural: supporters can help sustain the app without the developers forcing everyone to pay for essential features. This matters because niche apps often face a choice: lock features behind subscriptions to survive, or keep everything free and risk shutting down. For readers who rely on Peptide Tracker to stay informed about peptide-related news, a founding-member program could be a welcome compromise. It signals the developers want community support and transparency, and it could keep the app available to people who can’t or won’t pay. It also matters for how specialized medical and scientific information gets distributed — funding models shape who has access. Caveats: the announcement doesn’t guarantee long-term sustainability. Crowdfunding or voluntary memberships can fall short, and the app may later shift its model if revenues don’t cover costs. There’s no indication of investor backing, regulatory changes, or promises of major new features in exchange for money. Also, supporting an app doesn’t substitute for medical advice; Peptide Tracker reports news but isn’t a doctor. If you’re tracking peptide treatments for health reasons, talk to a clinician rather than relying solely on an app’s updates. Bottom line: Peptide Tracker is asking users to support it as founding members so it can stay free for everyone — it’s a funding choice, not a scientific or medical development.
Source: Lelezard